Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone as an adjuvant to bupivacaine femoral nerve block in adults with isolated femur fracture in the emergency room
PACTR202610665547008Phase 2Not yet recruiting
- Sponsor
- Menoufia University Hospitals
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexamethasone and bupivacaine in femoral fracture (2 arms), sponsored by Menoufia University Hospitals. Primary endpoint: Duration of analgesia. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexamethasonebupivacaine
03
Conditions
femoral fracture
Beyond the preview
Go deeper on PACTR202610665547008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202610665547008.